These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26302786)

  • 1. Bullous Delayed Pressure Urticaria Responding to Omalizumab.
    Müller S; Rafei-Shamsabadi D; Technau-Hafsi K; Renzel S; Jakob T
    Acta Derm Venereol; 2016 Mar; 96(3):416-7. PubMed ID: 26302786
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: case series.
    Netchiporouk E; Nguyen CH; Thuraisingham T; Jafarian F; Maurer M; Ben-Shoshan M
    Pediatr Allergy Immunol; 2015 Sep; 26(6):585-8. PubMed ID: 26012951
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of omalizumab in severe chronic spontaneous urticaria: Real life data from a Greek tertiary center.
    Kyriakou A; Trigoni A; Sotiriadis D; Patsatsi A
    Dermatol Ther; 2018 Nov; 31(6):e12739. PubMed ID: 30194796
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed bullous pressure urticaria: the puzzling role of eosinophils.
    Weins AB; Mourantchanian V; Eyerich S; Biedermann T; Brockow K
    J Dtsch Dermatol Ges; 2018 Oct; 16(10):1253-1255. PubMed ID: 30300481
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful omalizumab treatment of severe solar urticaria in a 6-year-old child.
    Levi A; Tal Y; Dranitzki Z; Shalit M; Enk CD
    Pediatr Allergy Immunol; 2015 Sep; 26(6):588-90. PubMed ID: 26172942
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria.
    Arasi S; Crisafulli G; Caminiti L; Guarneri F; Aversa T; Porcaro F; Pajno GB
    Pediatr Allergy Immunol; 2015 Sep; 26(6):583-5. PubMed ID: 26033828
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of occupational delayed pressure urticaria and angioedema with omalizumab.
    Geller M
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):81-2. PubMed ID: 26602491
    [No Abstract]   [Full Text] [Related]  

  • 8. Refractory solar urticaria successfully treated with omalizumab with normalization of phototest.
    Combalia A; Fernández-Sartorio C; Aguilera P
    Actas Dermosifiliogr; 2017; 108(6):593-594. PubMed ID: 28168968
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of omalizumab in severe solar urticaria.
    de Dios-Velázquez Á; González-de Arriba M; Beteta-Gorriti V; Macías E; Campanón-Toro V; Dávila I
    Ann Allergy Asthma Immunol; 2016 Mar; 116(3):260-2. PubMed ID: 26803538
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic Idiopathic Urticaria.
    Wu EY; Saini SS
    J Allergy Clin Immunol Pract; 2015; 3(6):1003-4; quiz 105. PubMed ID: 26553623
    [No Abstract]   [Full Text] [Related]  

  • 11. Blisters in disguise.
    Dowlatshahi EA; Diercks G; van Doorn M
    BMJ; 2018 Jan; 360():j5364. PubMed ID: 29301743
    [No Abstract]   [Full Text] [Related]  

  • 12. "Chronic Urticaria": Recommendations From an Allergist and Immunologist.
    Awosika O; Qureshi A; Ehrlich A; Fonacier L
    Dermatitis; 2018; 29(5):292-293. PubMed ID: 30179970
    [No Abstract]   [Full Text] [Related]  

  • 13. Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study.
    Aubin F; Avenel-Audran M; Jeanmougin M; Adamski H; Peyron JL; Marguery MC; Léonard F; Puyraveau M; Viguier M;
    J Am Acad Dermatol; 2016 Mar; 74(3):574-5. PubMed ID: 26892659
    [No Abstract]   [Full Text] [Related]  

  • 14. Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid.
    Seyed Jafari SM; Feldmeyer L; Bossart S; Simon D; Schlapbach C; Borradori L
    Front Immunol; 2020; 11():611549. PubMed ID: 33584689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab in the Treatment of Chronic Inducible Urticaria.
    Chicharro P; Rodríguez P; de Argila D
    Actas Dermosifiliogr; 2017 Jun; 108(5):423-431. PubMed ID: 27717421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab use during pregnancy for CIU: a tertiary care experience.
    Cuervo-Pardo L; Barcena-Blanch M; Radojicic C
    Eur Ann Allergy Clin Immunol; 2016 Jul; 48(4):145-6. PubMed ID: 27425170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blistering Langerhans cell histiocytosis.
    Chan MMH; Tan DJA; Koh MJ; Tan LS
    Lancet Oncol; 2018 Sep; 19(9):e500. PubMed ID: 30191853
    [No Abstract]   [Full Text] [Related]  

  • 18. Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria.
    Metz M; Ohanyan T; Church MK; Maurer M
    JAMA Dermatol; 2014 Mar; 150(3):288-90. PubMed ID: 24477320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urticarial vasculitis with blister formation: bullous (vesicular) urticarial vasculitis.
    Naito Y; Nishioka K; Sarashi C; Sano S; Yonemasu K
    J Dermatol; 1982 Dec; 9(6):481-4. PubMed ID: 6763050
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness in the treatment of solar urticaria with omalizumab: Report of 7 cases.
    Sahuquillo-Torralba A; Rodríguez-Serna M; Botella Estrada R
    Med Clin (Barc); 2018 Dec; 151(11):460-461. PubMed ID: 29526307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.